Ledger.Open graph →
SEC Form D · filed January 18, 2022

SV Biotech Crossover Opportunities Fund LP

Offering
$350.0M
Sold
$135.2M
Exemption
Rule 506(b)
Industry
Pooled Investment Fund
Location
LONDON, United Kingdom
Type
Pooled fund

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (12)

Houman Ashrafian · London, United KingdomExecKate Bingham · London, United KingdomExecSv Bco I Gp Llp · London, United KingdomExec · DirectorSv Health Managers Llp · London, United KingdomPromoterEdward T. Van Brunt · Phoenix, AZExecBruce H. Cox · Palm Beach, FLExecNicola Trbovic · London, United KingdomExecCarlyon Knight-Evans · Mid-Levels West, Hong KongExecDaniel P. Stauder · Willowbrook, ILExecSv Bco I Gp Llp · London, United KingdomExec · DirectorSv Health Managers Llp · London, United KingdomPromoterNicola Trbovic · London, United KingdomExec

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗